NASDAQ: BLRX
Biolinerx Ltd Stock Ownership - Who owns Biolinerx?

Insider buying vs selling

Have Biolinerx Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when BLRX insiders and whales buy or sell their stock.

BLRX Shareholders

What type of owners hold Biolinerx Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Citadel Advisors LLC0.00%14,954$55.93kInstitution
Simplex Trading LLC0.00%14,114$52.79kInstitution
Two Sigma Securities LLC0.00%13,816$51.67kInstitution
Susquehanna International Group LLP0.00%11,098$41.51kInstitution
Rhumbline Advisers0.00%4,275$15.99kInstitution
Citigroup Inc0.00%4,005$14.98kInstitution
Wells Fargo Company0.00%1,750$6.55kInstitution
Morgan Stanley0.00%1,543$5.77kInstitution
Nemes Rush Group LLC0.00%250$935.00Institution
National Bank Of Canada0.00%200$748.00Institution

1 of 2

BLRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BLRX0.00%0.00%
PULM4.69%95.31%
CYCC0.16%99.84%Net SellingNet Selling
BCAB26.97%35.39%Net SellingNet Selling
HOTH1.98%57.25%

Biolinerx Stock Ownership FAQ

Who owns Biolinerx?

Biolinerx (NASDAQ: BLRX) is owned by 0.00% institutional shareholders, 0.00% Biolinerx insiders, and 100.00% retail investors. Citadel Advisors LLC is the largest individual Biolinerx shareholder, owning 14,954.00 shares representing 0.00% of the company. Citadel Advisors LLC's Biolinerx shares are currently valued at $55.93k.

If you're new to stock investing, here's how to buy Biolinerx stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.